KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function
Kinisha Gala(Memorial Sloan Kettering Cancer Center), Sarat Chandarlapaty(Memorial Sloan Kettering Cancer Center)
Cited by 149
Related Papers
Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence
|Oncogene|2016|430
HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway
|Nature Communications|2021|86
Mutant SF3B1 promotes AKT- and NF-κB–driven mammary tumorigenesis
|Journal of Clinical Investigation|2020|45
Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion
|Cancer Cell|2024|44
EGFR-directed antibodies promote HER2 ADC internalization and efficacy
|Cell Reports Medicine|2024|27